Work

Post hoc pooled analyses of open-label and randomized controlled trials of senolytics dasatinib and quercetin in Idiopathic Pulmonary Fibrosis

Year: 2023

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2023.oa2583

Authors: Dean Kellogg, Anoop Nambiar, Jaime Justice, Martin Goros, Jonathan Gelfond, Rodolfo Pascual, Shahrukh Hashmi, Michal Masternak, Larissa Prata, Nathan Lebrasseur, Andrew Limper, Steven Kritchevsky, Nicholas Musi, Tamar Tchkonia, James Kirkland

Institutions: The University of Texas at San Antonio Health Science Center, Wake Forest University Health Sciences, Wake Forest University, Mayo Clinic, University of Central Florida

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387979797

Cites:

Cited by: 1

Related to: 10